about
Cell-free DNA from human plasma and serum differs in content of telomeric sequences and its ability to promote immune response.The leiomyomatous stroma in renal cell carcinomas is polyclonal and not part of the neoplastic process.Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele.Performance of Droplet Digital PCR in Non-Invasive Fetal RHD Genotyping - Comparison with a Routine Real-Time PCR Based ApproachDNA from microdissected tissues may be extracted and stored on microscopic slides.Application of the new insertion-deletion polymorphism kit for forensic identification and parentage testing on the Czech populationCell-free nucleic acids as biomarkers in dialyzed patients.NETosis provides the link between activation of neutrophils on hemodialysis membrane and comorbidities in dialyzed patientsForensic interlaboratory evaluation of the ForFLUID kit for vaginal fluids identification.Asymptomatic abdominal aortic aneurysms show histological signs of progression: a quantitative histochemical analysis.Methylation status of immune response genes promoters in cell-free DNA differs in hemodialyzed patients with diabetic nephropathy according to the intensity of anemia therapy.Alterations in methylation status of immune response genes promoters in cell-free DNA during a hemodialysis procedure.Differentially expressed miRNAs in trisomy 21 placentas.Oncocytic papillary carcinoma with lymphoid stroma (Warthin-like tumour) of the thyroid: a distinct entity with favourable prognosis.Genome-wide methylation analysis of tubulocystic and papillary renal cell carcinomas.MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection.Comparison of MicroRNA Content in Plasma and Urine Indicates the Existence of a Transrenal Passage of Selected MicroRNAs.[Possibilities of molecular genetic determination of age of an individual from biological traces].The impact of standard chemotherapy on miRNA signature in plasma in AML patientsQuantification of circulating fetal DNA as a tool for potential monitoring of pregnant patients with antiphospholipid antibodiesApplication of multifactor dimensionality reduction analysis and Bayesian networks for eye color and ancestry prediction for forensic purposes in the Czech RepublicCell-Free Fetal DNA in Maternal Plasma during Physiological Single Male Pregnancies: Methodology Issues and KineticsCell-Free Plasma DNA during Peritoneal Dialysis and Hemodialysis and in Patients with Chronic Kidney DiseasePrimersITS1, ITS2 andITS4 detect the intraspecies variability in the internal transcribed spacers and 5.8S rRNA gene region in clinical isolates of fungiTubulocystic renal cell carcinoma: is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases[Determination of body fluid based on analysis of nucleic acids]How to Characterize Fetal Cells from the Maternal Circulation?
P50
Q33752880-785CE665-1272-41B1-A604-A1950B07F3B5Q34420473-FC659C84-3C15-4178-8F21-31176F515CE7Q34621895-5CCEDCB6-9C8D-4F80-B0BF-133EA3A4E5B5Q35839919-7B42925B-E361-421C-927E-FD9F140D9509Q36042916-7CC543D8-6F0B-4DE6-9DFE-2647C2BE1A32Q36511436-4A64FC27-16F3-4391-A6AE-E987DF273831Q38163922-F00F7478-E100-4142-B117-78D82F04DAA8Q39019253-6E7BFB33-5975-4CE8-A0F3-BEACE9592F7CQ40160002-97FA1D9C-DB11-477A-8DC8-0B193DB296A6Q43509058-4CFDA63B-D8F5-4A7E-B711-B47A75F3D1DBQ43976918-63697FAD-4D1F-42B3-8ADF-0089BEFDE46EQ47899514-BE98B70C-82E2-475B-9F08-AC735FD989A5Q48193333-A31544DA-34E7-4EAF-8CC9-C88FC9093B22Q49212476-81FB413B-047A-4E6A-A668-9F2A7B29CCBCQ53205522-A3D9C057-F82A-4641-8EAD-E254A3DEBBDDQ53710759-F5D439E1-B6D4-43F4-8960-470A04F2A77CQ54141798-DA1D57F5-DB69-47FC-82E4-19A248FA3790Q54184172-7D18AB56-81CE-4053-9485-33EF60E2EB67Q57557759-549AE087-A4C9-4649-BBC7-2DFB6A92529BQ57557766-D5BCC99D-B255-4897-8C7E-2A722203F1DCQ57557771-B94BC19E-057B-426C-9CAE-67ADFF2C384EQ57557794-A69D75D2-9EB0-4099-AE41-B45A0DF78B3AQ57557797-60833AC9-7AD7-47DE-99A0-975C61CB17E3Q60283606-BC24A265-3982-48D2-98FE-6A1022C32F34Q85849574-E792ABA2-C487-4C28-A8A6-7B1C1C4DEA1AQ86318450-DDCC770C-AE85-4E09-A987-F935DC2BFB2CQ86719005-0FE4069C-B88D-49B6-9DA3-896A2D2E47DF
P50
description
molekulární genetička
@cs
researcher ORCID ID = 0000-0003-2438-817X
@en
wetenschapper
@nl
name
Marie Korabecna
@ast
Marie Korabecna
@es
Marie Korabecna
@nl
Marie Korabečná
@cs
Marie Korabečná
@en
type
label
Marie Korabecna
@ast
Marie Korabecna
@es
Marie Korabecna
@nl
Marie Korabečná
@cs
Marie Korabečná
@en
prefLabel
Marie Korabecna
@ast
Marie Korabecna
@es
Marie Korabecna
@nl
Marie Korabečná
@cs
Marie Korabečná
@en
P214
P1153
6602654662
P21
P214
P31
P496
0000-0003-2438-817X
P569
1961-02-01T00:00:00Z
P691
P735
P7859
viaf-85760972